IP Library Granted Patent US 7,186,422
Granted Patent B2
US 7,186,422 · App. 10/993,883 · Granted Mar 6, 2007

Preventative and treatment effects of

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,186,422
App. No.
10/993,883
Granted
Mar 6, 2007
Kind
B2
Abstract

The present invention features a unique, natural formulation and method of administering the same to treat and prevent diabetes, or rather advances treatment of diabetes, by providing a naturaceutical composition or treatment formulated with one or more processed Morinda citrifolia products as derived from the Indian Mulberry plant. The Morinda citrifolia is particularly adapted to treat Type II diabetes. The Morinda citrifolia product is preferably a leaf extract, but may also be in the form of a juice, a puree juice, a dietary fiber, or other similar forms and is incorporated into various carriers or naturaceutical compositions suitable for in vivo treatment of a patient. The naturaceutical may also combine other food products into the naturaceutical, such as fruit juices, dietary supplements, vitamins and minerals, and others.

Claims (15)

1. A formulation for treating diabetes comprising:

a formulation comprising a processed Morinda citrifolia leaf hot water extract present in an amount by weight between about 0.1 and 50 percent;

quercetin;

rutin; and

an ingredient selected from the group consisting of a combination of processed Morinda citrifolia products, food supplements, dietary supplements, and flavorings, wherein said quercetin is present in an amount between about 0.1 and 10 percent by weight and wherein said rutin is present in an amount between about 0.1 and 10 percent by weight.

2. The formulation of claim 1 , wherein said formulation further comprises a processed Morinda citrifolia leaf ethanol extract present in an amount by weight between about 0.1 and 50 percent.

3. The formulation of claim 1 , wherein said formulation further comprises a processed Morinda citrifolia leaf steam distillation extract present in an amount by weight between about 0.1 and 50 percent.

4. The formulation of claim 1 , wherein said formulation further comprises Morinda citrifolia fruit juice.

5. The formulation of claim 1 , wherein said formulation further comprises Morinda citrifolia puree juice.

6. The formulation of claim 1 , wherein said formulation further comprises Morinda citrifolia puree juice concentrate.

7. The formulation of claim 1 , wherein said formulation further comprises Morinda citrifolia fruit juice concentrate.

8. The formulation of claim 1 , wherein said formulation further comprises Morinda citrifolia dietary fiber.

9. The formulation of claim 1 , wherein said formulation is administered orally.

10. The formulation of claim 1 , wherein said formulation is administered intravenously.

11. The formulation of claim 1 , wherein said formulation is administered systemically.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 5, 2007
From: MORINDA, INC.
To: TAHITIAN NONI INTERNATIONAL, INC.
Reel/Frame 018851/0222 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 28, 2005
From: JENSEN, CLAUDE JARAKAE; PALU, AFA KEHAATI; OHISHI, HIFUMI; TANI, HISANORI
To: MORINDA, INC.
Reel/Frame 015982/0473 →